Navigation Links
BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation
Date:6/30/2010

BOSTON Akash Patnaik, MD, PhD, a physician-scientist in the Hematology/Oncology Divison at Beth Israel Deaconess Medical Center (BIDMC) and Instructor of Medicine at Harvard Medical School has received a Young Investigator Award from The Prostate Cancer Foundation (PCF). The three-year $225,000 award, one of 21 made to young scientists from across the U.S. and Canada, is designed to encourage the most innovative minds in cancer research to focus their careers on prostate cancer.

Patnaik's research focuses on the relationship between diet-induced obesity /associated metabolic abnormalities and prostate cancer. With the PCF funding, he will investigate the molecular mechanisms that link the metabolic abnormalities of obesity to poor outcomes in prostate cancer patients.

"Hormones, such as insulin, are increased in obese patients and are known to drive the progression and survival of prostate cancer cells," Patnaik explains. "Recent epidemiological studies have shown that men who are treated with metformin, a medication prescribed for Type 2 diabetes, have a reduced risk of prostate cancer." Patnaik will evaluate the anti-cancer mechanism and efficacy of metformin and related medications to prolong overall survival of patients with advanced prostate cancer.

"Obesity is strongly associated with poor prostate cancer prognosis," notes Lewis Cantley, PhD, Patnaik's postdoctoral research mentor and Director of BIDMC's Cancer Center and William Bosworth Castle Professor of Medicine at Harvard Medical School. "Dr. Patnaik's investigations promise to provide us with a better understanding of the molecular events that drive obesity-induced cancers, and provide a rationale for a new metabolic treatment strategy for advanced prostate-cancer patients."

Patnaik will utilize a "co-clinical trial paradigm" to identify novel targeted therapies for advanced prostate cancer patients. In this way he will assess the responses of genetically engineered mouse models to specific cancer drugs, and then use this information to stratify patients into specific treatment arms, based on patients' cancer mutations and their individual metabolic profiles.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers suggest new paradigm for breast cancer screening
2. Of lice and man: Researchers sequence human body louse genome
3. AcademyHealth honors leading health services researchers
4. UCLA researchers, US military collaborate to open center for traumatic brain injury
5. Texas A&M researcher explains how embryo fights retroviral infection
6. UC San Diego researcher awarded $5.3 million for breast cancer survivorship study
7. UCSD researchers receive $2.5 million in new stem cell grants
8. Researchers find key to getting estrogens benefits without cancer risk
9. Mount Sinai researchers find structural basis for incidence of skin cancers in a genetic disorder
10. WSU researchers find mothers of children with autism pay price in workplace
11. Free Resources from EBSCO Publishing Providing Useful Information to Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: